GRNA Новости Форекс
GreenLight Biosciences, Epivax Ink Collaboration Deal To Develop Personalized Cancer Vaccines
Biotechnology company GreenLight Biosciences Holdings, PBC (GRNA), and EpiVax Therapeutics Inc, announced Monday that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers.
RTTNews
|
759 дней спустя
